Kerui Biopharmaceutical Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 110

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Kerui Biopharmaceutical General Information

Description

Manufacturer of active pharmaceutical ingredients designed for the development of steroid hormones and medicinal products. The company utilizes stigmasterol as a starting material to develop steroid hormone materials, plant-origin cholesterol materials, and plant-origin cholic acid materials, thereby enabling pharmaceutical companies with cholesterol, vitamin D3, medroxyprogesterone acetate, budesonide, finasteride, and dutasteride to enable the production of specialized medications.

Contact Information

Formerly Known As
Hunan Kerui Biotechnology
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Caixing Road, Daping Economic Development Zone, Niangxi Town
  • Xinshao County
  • Shaoyang, Hunan 422900
  • China
+86 0739
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Specialty Chemicals
Vertical(s)
Corporate Office
  • Caixing Road, Daping Economic Development Zone, Niangxi Town
  • Xinshao County
  • Shaoyang, Hunan 422900
  • China
+86 0739

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kerui Biopharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kerui Biopharmaceutical‘s full profile, request access.

Request a free trial

Kerui Biopharmaceutical Patents

Kerui Biopharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023082368-A1 4-azasteroid compound, and preparation method therefor and use thereof Inactive 15-Nov-2021
WO-2022100722-A1 5,6-epoxy sterol compound, preparation method therefor and application thereof Inactive 14-Nov-2020
WO-2021120127-A1 Method for preparing cholesterol, derivative and analogue thereof Inactive 19-Dec-2019
EP-3967700-A1 Method for preparing cholesterol, derivative thereof, and analog thereof Active 19-Dec-2019
EP-3967700-A4 Method for preparing cholesterol, derivative thereof, and analog thereof Active 19-Dec-2019 C07J9/00
To view Kerui Biopharmaceutical’s complete patent history, request access »

Kerui Biopharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kerui Biopharmaceutical FAQs

  • When was Kerui Biopharmaceutical founded?

    Kerui Biopharmaceutical was founded in 2005.

  • Where is Kerui Biopharmaceutical headquartered?

    Kerui Biopharmaceutical is headquartered in Shaoyang, China.

  • What is the size of Kerui Biopharmaceutical?

    Kerui Biopharmaceutical has 110 total employees.

  • What industry is Kerui Biopharmaceutical in?

    Kerui Biopharmaceutical’s primary industry is Pharmaceuticals.

  • Is Kerui Biopharmaceutical a private or public company?

    Kerui Biopharmaceutical is a Private company.

  • What is the current valuation of Kerui Biopharmaceutical?

    The current valuation of Kerui Biopharmaceutical is .

  • What is Kerui Biopharmaceutical’s current revenue?

    The current revenue for Kerui Biopharmaceutical is .

  • How much funding has Kerui Biopharmaceutical raised over time?

    Kerui Biopharmaceutical has raised $2.13M.

  • When was Kerui Biopharmaceutical acquired?

    Kerui Biopharmaceutical was acquired on 27-Mar-2022.

  • Who acquired Kerui Biopharmaceutical?

    Kerui Biopharmaceutical was acquired by Zhejiang Anglikang Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process